ARF3ADP ribosylation factor 3
Autism Reports / Total Reports
3 / 5Rare Variants / Common Variants
11 / 0Chromosome Band
12q13.12Associated Disorders
-Genetic Category
Rare Single Gene Mutation, SyndromicRelevance to Autism
Three rare and potentially damaging de novo missense variants in the ARF3 gene were identified in ASD probands from the SPARK cohort (Feliciano et al., 2019; Zhou et al., 2022). Transmission and de novo association (TADA) analysis of whole-exome and whole-genome sequencing data from the Autism Sequencing Consortium, the Simons Simplex Collection, the MSSNG cohort, and the SPARK cohort in Trost et al., 2022 identified ARF3 as an ASD-associated gene with a false discovery rate (FDR) < 0.1. De novo missense variants in ARF3 have also been shown to cause a neurodevelopmental syndrome characterized by developmental delay/intellectual disability, epilepsy, and brain abnormalities (Sakamoto et al., 2021; Fasano et al., 2022).
Molecular Function
GTP-binding protein that functions as an allosteric activator of the cholera toxin catalytic subunit, an ADP-ribosyltransferase. Involved in protein trafficking; may modulate vesicle budding and uncoating within the Golgi apparatus.
External Links
SFARI Genomic Platforms
Reports related to ARF3 (5 Reports)
# | Type | Title | Author, Year | Autism Report | Associated Disorders |
---|---|---|---|---|---|
1 | Primary | Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes | Feliciano P et al. (2019) | Yes | - |
2 | Support | - | Sakamoto M et al. (2021) | No | ID |
3 | Support | - | Zhou X et al. (2022) | Yes | - |
4 | Recent Recommendation | - | Trost B et al. (2022) | Yes | - |
5 | Support | - | Fasano G et al. (2022) | No | Epilepsy/seizures |
Rare Variants (11)
Status | Allele Change | Residue Change | Variant Type | Inheritance Pattern | Parental Transmission | Family Type | PubMed ID | Author, Year |
---|---|---|---|---|---|---|---|---|
c.224G>A | p.Arg75Gln | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.394A>G | p.Asn132Asp | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.34C>G | p.Leu12Val | missense_variant | De novo | - | - | 36369169 | Fasano G et al. (2022) | |
c.95C>A | p.Thr32Asn | missense_variant | De novo | - | - | 36369169 | Fasano G et al. (2022) | |
c.139C>T | p.Pro47Ser | missense_variant | De novo | - | - | 36369169 | Fasano G et al. (2022) | |
c.200A>T | p.Asp67Val | missense_variant | De novo | - | - | 36369169 | Fasano G et al. (2022) | |
c.277G>A | p.Asp93Asn | missense_variant | De novo | - | - | 36369169 | Fasano G et al. (2022) | |
c.379A>G | p.Lys127Glu | missense_variant | De novo | - | - | 36369169 | Fasano G et al. (2022) | |
c.74T>C | p.Leu25Pro | missense_variant | De novo | - | - | 31452935 | Feliciano P et al. (2019) | |
c.200A>T | p.Asp67Val | missense_variant | De novo | - | Simplex | 34346499 | Sakamoto M et al. (2021) | |
c.296G>T | p.Arg99Leu | missense_variant | De novo | - | Simplex | 34346499 | Sakamoto M et al. (2021) |
Common Variants
No common variants reported.
SFARI Gene score
High Confidence


Score Delta: Score remained at 1
criteria met
See SFARI Gene'scoring criteriaWe considered a rigorous statistical comparison between cases and controls, yielding genome-wide statistical significance, with independent replication, to be the strongest possible evidence for a gene. These criteria were relaxed slightly for category 2.
1/1/2023

Increased from to 1
Krishnan Probability Score
Score 0.57424549025352
Ranking 676/25841 scored genes
[Show Scoring Methodology]
ExAC Score
Score 0.62273132360694
Ranking 4885/18225 scored genes
[Show Scoring Methodology]
Sanders TADA Score
Score 0.90505289385323
Ranking 6918/18665 scored genes
[Show Scoring Methodology]
Zhang D Score
Score 0.38426456735319
Ranking 1639/20870 scored genes
[Show Scoring Methodology]